The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
Mirza MU, Alanko I, Vanmeert M, Muzzarelli KM, Salo-Ahen OMH, Abdullah I, Kovari IA, Claes S, De Jonghe S, Schols D, Schinazi RF, Kovari LC, Trant JF, Ahmad S, Froeyen M.
Mirza MU, et al.
Eur J Pharm Sci. 2022 Aug 1;175:106220. doi: 10.1016/j.ejps.2022.106220. Epub 2022 May 23.
Eur J Pharm Sci. 2022.
PMID: 35618201
Free article.